SIFO is small intestinal fungal overgrowth
Therefore, BMP4 becomes a potential therapeutic target in CRC, especially in a diabetic context where high blood glucose significantly affects cancer progression through the BMP4 pathway
However, after oral or systemic administration, Dex lacks organ-targeting capabilities, so higher doses and frequencies are required to achieve effective concentrations at the site of inflammation [103], which causes severe side effects on the hematological and alimentary systems [104]
BPC-157 lacks that level of validation
however, certain conditions preclude or caution against Glycine Injection (50 mg/mL) because of adverse-outcome risk
Romhnyi D, Szab K, Kemny L, Groma G